BioCrossroads Indiana Seed Fund II makes first investments in cutting-edge start-up companies Esanex and Algaeon
Indianapolis, January 10, 2013 - BioCrossroads Indiana Seed Fund II has made its first two investments: Esanex, a company developing an oncology drug, and Algaeon, which has developed an algae cultivation technology for use in the nutraceutical and micronutrient markets. The Indiana Seed Fund II is an $8.25 million early-stage fund focused on identifying, ...
